Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ni Li

Showing results (741-750 of 890) with videos related to

Pageof 89
Sort By:
Nature Communications|September 18, 2023
Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesisTing Huang, Ruyi Lin, Yuanqin Su, et al.
International Journal of Cancer|April 10, 2007
Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisationRui-fang Wu, Min Dai, You-lin Qiao, et al.
Frontiers in Oncology|August 15, 2020
Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced AdenomaHejing Wang, Bei Zhang, Xiaojin Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2024
Mammographic Density in Relation to Breast Cancer Risk Factors among Chinese WomenHela Koka, Yuan Tian, Lu Deng, et al.
Cancer Letters|June 12, 2026
Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation studyChenran Wang, Xuesi Dong, Guochao Zhang, et al.
Journal of Clinical Medicine|January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial CancerChun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Cell Death and Differentiation|May 14, 2022
Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activationJia Yuan, Qingchen Zhu, Xingli Zhang, et al.
Cancer Innovation|January 22, 2026
Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskXuesi Dong, Jiaxin Xie, Zilin Luo, et al.
Expert Opinion on Investigational Drugs|May 6, 2025
A phase 1, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of KN056 (a recombinant human GLP-1 variant Fc fusion protein) in healthy Chinese participantsYuan-Fang Qin, Wen-Hua Zhang, Hao-Nan Zhang, et al.
Frontiers in Immunology|October 6, 2025
TGM2 regulated by transcription factor NR3C1 drives p38 MAPK-mediated tumor progression and immune evasion in lung squamous cell carcinomaChunlong Lin, Shangfu Li, Liang Yi, et al.
Pageof 89

Showing results (741-750 of 890) with videos related to

Sort By:
Pageof 89
Nature Communications|September 18, 2023
Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesisTing Huang, Ruyi Lin, Yuanqin Su, et al.
International Journal of Cancer|April 10, 2007
Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisationRui-fang Wu, Min Dai, You-lin Qiao, et al.
Frontiers in Oncology|August 15, 2020
Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced AdenomaHejing Wang, Bei Zhang, Xiaojin Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2024
Mammographic Density in Relation to Breast Cancer Risk Factors among Chinese WomenHela Koka, Yuan Tian, Lu Deng, et al.
Cancer Letters|June 12, 2026
Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation studyChenran Wang, Xuesi Dong, Guochao Zhang, et al.
Journal of Clinical Medicine|January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial CancerChun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Cell Death and Differentiation|May 14, 2022
Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activationJia Yuan, Qingchen Zhu, Xingli Zhang, et al.
Cancer Innovation|January 22, 2026
Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskXuesi Dong, Jiaxin Xie, Zilin Luo, et al.
Expert Opinion on Investigational Drugs|May 6, 2025
A phase 1, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of KN056 (a recombinant human GLP-1 variant Fc fusion protein) in healthy Chinese participantsYuan-Fang Qin, Wen-Hua Zhang, Hao-Nan Zhang, et al.
Frontiers in Immunology|October 6, 2025
TGM2 regulated by transcription factor NR3C1 drives p38 MAPK-mediated tumor progression and immune evasion in lung squamous cell carcinomaChunlong Lin, Shangfu Li, Liang Yi, et al.
Pageof 89